Skip to main content
Clinical Trials/JPRN-UMIN000027243
JPRN-UMIN000027243
Completed
未知

Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularization - Anti-VEGF therapy for ocular neovascularization

School of Medicine Toho University0 sites20 target enrollmentMay 4, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
retinopathy of prematurity neovascular glaucome vasoproliferative tumor choroidal neovascularization
Sponsor
School of Medicine Toho University
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 4, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
School of Medicine Toho University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1, high risk of stroke infarction 2, high risk of myocardial infarction 3, ocular infection

Outcomes

Primary Outcomes

Not specified

Similar Trials